^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Prostate Cancer
    Drug:Lutrate (leuprorelin depot) (GnRH agonist)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    New
    Source:
    FDA
    Excerpt:
    LUTRATE DEPOT is a gonadotropin-releasing hormone (GnRH) agonist indicated for:….Treatment of advanced prostate cancer.